Pratik S. Multani

CIK: 0001586894

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (10.5%)

Position reduction

Option Exercises (M)2 (10.5%)

Derivative conversions

Awards (A)7 (36.8%)

Compensation grants

Other (G, F, J, C, D, …)8 (42.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

ERAS

Erasca, Inc.

Director

ORIC

Oric Pharmaceuticals, Inc.

Officer

CMRX

CHIMERIX INC

Director

Discretionary Trading P&L

Holdings

Transaction History (19 total)

ERAS
Erasca, Inc.
Jun 26, 2026
Award(A)
Stock option (right to buy)
Direct
29.9K shares-
ORIC
Oric Pharmaceuticals, Inc.
Jan 2, 2026
Award(A)
Restricted Stock Unit
Direct
35.5K shares-
ORIC
Oric Pharmaceuticals, Inc.
Jan 2, 2026
Award(A)
Stock Option (right to buy)
Direct
214K shares-
ERAS
Erasca, Inc.
Jan 1, 2026
Award(A)
Stock Option (right to buy)
Direct
19.5K shares-
ORIC
Oric Pharmaceuticals, Inc.
Dec 16, 2025
Sale(S)
Direct
10.7K shares at avg. $9.06$97K
ORIC
Oric Pharmaceuticals, Inc.
Dec 15, 2025
Exercise(M)
Direct
29.3K shares-
ERAS
Erasca, Inc.
Jun 24, 2025
Award(A)
Stock option (right to buy)
Direct
120K shares-
ERAS
Erasca, Inc.
May 23, 2025
Gift(G)
Indirect
6.2K shares-
ERAS
Erasca, Inc.
May 23, 2025
Gift(G)
Direct
6.2K shares-
CMRX
CHIMERIX INC
Apr 21, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
35K shares-
CMRX
CHIMERIX INC
Apr 21, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
60K shares-
CMRX
CHIMERIX INC
Apr 21, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
35K shares-
CMRX
CHIMERIX INC
Apr 21, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
50K shares-
CMRX
CHIMERIX INC
Apr 21, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
60K shares-
CMRX
CHIMERIX INC
Apr 21, 2025
Disposition(D)
Employee Stock Option (Right to Buy)
Direct
60K shares-
ORIC
Oric Pharmaceuticals, Inc.
Jan 2, 2025
Award(A)
Stock Option (right to buy)
Direct
202.5K shares-
ORIC
Oric Pharmaceuticals, Inc.
Jan 2, 2025
Award(A)
Restricted Stock Unit
Direct
34K shares-
ORIC
Oric Pharmaceuticals, Inc.
Dec 16, 2024
Sale(S)
Direct
8.9K shares at avg. $8.28$73K
ORIC
Oric Pharmaceuticals, Inc.
Dec 15, 2024
Exercise(M)
Direct
24K shares-

		Type	Shares	Price		Ownership
Jun 26, 2026	ERAS Erasca, Inc.	Award(A) Stock option (right to buy)	29,888	-	-	Direct
Jan 2, 2026	ORIC Oric Pharmaceuticals, Inc.	Award(A) Restricted Stock Unit	35,500	-	-	Direct
Jan 2, 2026	ORIC Oric Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	214,000	-	-	Direct
Jan 1, 2026	ERAS Erasca, Inc.	Award(A) Stock Option (right to buy)	19,532	-	-	Direct
Dec 16, 2025	ORIC Oric Pharmaceuticals, Inc.	Sale(S)	10,720	$9.06	$97,129	Direct
Dec 15, 2025	ORIC Oric Pharmaceuticals, Inc.	Exercise(M)	29,333	-	-	Direct
Jun 24, 2025	ERAS Erasca, Inc.	Award(A) Stock option (right to buy)	120,000	-	-	Direct
May 23, 2025	ERAS Erasca, Inc.	Gift(G)	6,200	-	-	Indirect
May 23, 2025	ERAS Erasca, Inc.	Gift(G)	6,200	-	-	Direct
Apr 21, 2025	CMRX CHIMERIX INC	Disposition(D) Employee Stock Option (Right to Buy)	35,000	-	-	Direct
Apr 21, 2025	CMRX CHIMERIX INC	Disposition(D) Employee Stock Option (Right to Buy)	60,000	-	-	Direct
Apr 21, 2025	CMRX CHIMERIX INC	Disposition(D) Employee Stock Option (Right to Buy)	35,000	-	-	Direct
Apr 21, 2025	CMRX CHIMERIX INC	Disposition(D) Employee Stock Option (Right to Buy)	50,000	-	-	Direct
Apr 21, 2025	CMRX CHIMERIX INC	Disposition(D) Employee Stock Option (Right to Buy)	60,000	-	-	Direct
Apr 21, 2025	CMRX CHIMERIX INC	Disposition(D) Employee Stock Option (Right to Buy)	60,000	-	-	Direct
Jan 2, 2025	ORIC Oric Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	202,500	-	-	Direct
Jan 2, 2025	ORIC Oric Pharmaceuticals, Inc.	Award(A) Restricted Stock Unit	34,000	-	-	Direct
Dec 16, 2024	ORIC Oric Pharmaceuticals, Inc.	Sale(S)	8,850	$8.28	$73,293	Direct
Dec 15, 2024	ORIC Oric Pharmaceuticals, Inc.	Exercise(M)	24,042	-	$0	Direct

1-19 of 19 transactions

About Multani Pratik S

Multani Pratik S (SEC CIK 0001586894) files insider reports with the SEC as Director of Erasca, Inc. (ERAS), Chief Medical Officer of Oric Pharmaceuticals, Inc. (ORIC) and Director of CHIMERIX INC (CMRX).

Signal8 holds 9 ownership filings by Multani Pratik S, all Form 4s, filed between Dec 17, 2024 and Jun 29, 2026. Those filings report 19 transactions, from Dec 15, 2024 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Multani Pratik S's filings is in SAN DIEGO, CA.

Recent filings by Multani Pratik S

Jun 26, 2026: Grant or award of ERAS derivative securities (Form 4, code A).
Jan 2, 2026: Grants or awards of ORIC derivative securities (2 lines, Form 4, code A).
Jan 1, 2026: Grant or award of ERAS derivative securities (Form 4, code A).
Dec 16, 2025: Open-market sale of ORIC shares (Form 4, code S).
Dec 15, 2025: Option exercise of ORIC shares (Form 4, code M).

Other insiders filing for Erasca, Inc. (ERAS)

How to read Form 4 transaction codes